NCT02185105

Brief Summary

The study hypothesis is there is no difference in the clinical performance between the test and control lenses, in particular in lens stability, toric mislocation, comfort ratings and anterior segment ocular health findings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 7, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 9, 2014

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

January 2, 2017

Completed
Last Updated

March 7, 2017

Status Verified

January 1, 2017

Enrollment Period

Same day

First QC Date

July 7, 2014

Results QC Date

August 2, 2016

Last Update Submit

January 24, 2017

Conditions

Outcome Measures

Primary Outcomes (19)

  • Lens Surface Assessment of Study Lenses - Surface Wettability

    Investigator's objective assessment of lens surface wettability at 15min and 6hrs. Scale (0-4; 0=non-wetting, 4=Excellent)

    15min & 6hrs

  • Lens Surface Assessment of Study Lenses - Deposits

    Investigator's objective assessment of lens surface deposition at 15min and 6hrs. Graded on the appearance of lens surface by slit lamp. Rated on a scale (0-4; 0=no deposits, 4=deposits ≥0.5mm or film \> 75% of surface)

    15min & 6hrs

  • Lens Surface Assessment of Study Lenses - Surface Acceptance

    Investigator's objective assessment of surface acceptance at 15min and 6hrs. Rated on a scale (0-4; 0=very poor, 4=excellent)

    15min & 6hrs

  • Subjective Rating For Comfort - Comfort Since Last Visit

    Participant's subjective rating of comfort now of study lenses. Surveyed at 15min, 3hr, and 6hr. Scale (0-100; 0=cannot be worn, causes pain, 100=cannot be felt ever)

    15min, 3hrs, 6hrs

  • Subjective Rating For Comfort Preference

    Participant's subjective rating of comfort preference of study lenses. Scale: (Strongly Prefer Right lens - Strongly Prefer Left Lens)

    1min, 15min, 3hrs, 6hrs

  • Subjective Rating For Handling - Insertion

    Participant's subjective rating for ease of insertion of the study lenses. Scale (0-100; 0=could not place lens on eye;100=always easy to place lens on eye)

    1 min

  • Subjective Rating For Handling - Removal

    Participant's subjective rating for ease of removal of study lenses. Scale (0-100; 0=could not remove lens from eye;100=always easy to place remove from eye)

    1 min

  • Investigator's Assessment of Stability

    Investigator's assessment of the study lenses overall stability difference measured from 0-180 degrees, 0=very good stability, 180=very bad stability.

    15min & 6hrs

  • General Lens Fit - Fit Acceptance

    Investigator's assessment for fit acceptance of study lenses. Scale: 0-4 (0=Should not be worn; 4=Perfect)

    15min & 6hrs

  • Lens Fitting - Rotation/Mislocation

    Investigator's observed the rotation/mislocation (toric mark) of study lenses from the desired 6 o'clock position following temp rotation 30 degrees, 10 blinks; rotation toward desired 6 o'clock position=(+); rotation away from desired 6 o'clock position=(-).

    Baseline, 15min & 6hrs

  • Anterior Ocular Health - Corneal Staining (Central)

    Corneal staining (central) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. (Scale 0-4, 0=No staining; 4= \>45% of area)

    baseline & 6hrs

  • Anterior Ocular Health - Corneal Staining (Nasal)

    Corneal staining (nasal) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. (Scale 0-4, 0=No staining; 4= \>45% of area)

    baseline & 6hrs

  • Anterior Ocular Health - Corneal Staining (Temporal)

    Corneal staining (temporal) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. (Scale 0-4, 0=No staining; 4= \>45% of area)

    baseline & 6hrs

  • Anterior Ocular Health - CornealStaining (Superior)

    Corneal staining (superior) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. (Scale 0-4, 0=No staining; 4= \>45% of area)

    baseline & 6hrs

  • Anterior Ocular Health - Corneal Staining (Inferior)

    Corneal staining (inferior) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. (Scale 0-4, 0=No staining; 4= \>45% of area)

    baseline & 6hrs

  • Anterior Ocular Health - Conjunctival Staining (Nasal)

    Conjunctival staining (nasal) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. Scale: 0-4, (0=None; 4=Deep confluent).

    baseline & 6hrs

  • Anterior Ocular Health - Conjunctival Staining (Superior)

    Conjunctival staining (superior) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. Scale: 0-4, (0=None; 4=Deep confluent).

    baseline & 6hrs

  • Anterior Ocular Health - Conjunctival Staining (Temporal)

    Conjunctival staining (temporal) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. Scale: 0-4, (0=None; 4=Deep confluent).

    baseline & 6hrs

  • Anterior Ocular Health - Conjunctival Staining (Inferior)

    Conjunctival staining (inferior) for comfilcon (A) toric and comfilcon (A) toric XR lenses assessed at baseline and 6 hours. Scale: 0-4, (0=None; 4=Deep confluent).

    baseline & 6hrs

Study Arms (2)

comfilcon A MTO

EXPERIMENTAL

Subjects will be randomized to receive either the Test or Control lens as a matched pair at each visit per a predetermined randomization schedule.

Device: comfilcon A

comfilcon A

ACTIVE COMPARATOR

Subjects will be randomized to receive either the Test or Control lens as a matched pair at each visit per a predetermined randomization schedule.

Device: comfilcon A MTO

Interventions

Randomized to a test lens in one eye and control lens in the other as a matched pair.

Also known as: Biofinity Toric MTO
comfilcon A

Randomized to a test lens in one eye and control lens in the other as a matched pair.

Also known as: Biofinity Toric
comfilcon A MTO

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has had a self-reported oculo-visual examination in the last two years.
  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Has read and understood the information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.
  • Currently wears soft contact lenses.
  • Has clear corneas and no active ocular disease.
  • Has not worn lenses for at least 12 hours before the examination

You may not qualify if:

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CORL, Indiana University

Bloomington, Indiana, 47405, United States

Location

MeSH Terms

Conditions

MyopiaAstigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Sr. Manager, Clinical Research
Organization
CooperVision, Inc

Study Officials

  • Pete S Kollbaum, O.D.

    Indiana University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2014

First Posted

July 9, 2014

Study Start

June 1, 2014

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

March 7, 2017

Results First Posted

January 2, 2017

Record last verified: 2017-01

Locations